Dianna Sue Howard, M.D.
Professor, Hematology & Oncology
Leukemia, Myeloid, Acute; Genetic Association Studies; Alzheimer Disease; Antineoplastic Combined Chemotherapy Protocols; RNA Stability
Academic: 336-716-4464 | Department: 336-716-4464
Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit. Ahmed T, Koch AL, Isom S, Klepin HD, Bishop JM, Ellis LR, Berenzon D, Howard D, Lyerly S, Powell BL, Pardee TS.. Leuk Res. 2017;62():51-55.
Acute graft-versus-host disease in the setting of T cell depletion: validation of a new agvhd risk score [abstract]. Saeed H, Slone S, Yalamanchi S, Becton T, Monohan G, Howard D, Herzig R, Hildebrandt GC.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S410-S411.
Timing of salvage therapy and autologous hematopoietic cell transplant in relapsed hodgkin and non hodgkin lymphoma [abstract]. Lamar ZS, Fino N, Hurd D, Howard D, McIver ZA, Phillips GL, Vaidya R.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S127-S128.
Simultaneous quantitation of oxidized and reduced glutathione via LC-MS/MS: an insight into the redox state of hematopoietic stem cells. Carroll D, Howard D, Zhu H, Paumi CM, Vore M, Bondada S, Liang Y, Wang C, St Clair DK.. Free Radic Biol Med. 2016;97():85-94.
Activity of the mitochondrial metabolism inhibitor cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone in high risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. Pardee TS, Stadelman K, Isom S, Ellis LR, Berenzon D, Hurd DD, Howard DS, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL.. J Clin Oncol. 2015;33(15 Suppl):7015.
The mitochondrial metabolism inhibitor Cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone is highly active in poor risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. Pardee T, Pladna K, Isom S, Ellis LR, Berenzon D, Howard D, Manuel M, Dralle S, Hurd DD, Lyerly S, Powell BL.. Blood. 2015;126(23):2556.
Feasibility of a symptom-adapted physical activity intervention during induction chemotherapy for older adults with acute myeloid leukemia (AML) [abstract]. Klepin HD, Tooze J, Pardee T, Ellis LR, Berenzon D, Howard D, Demark-Wahnefried W, Mihalko S, Rejeski WJ, Powell BL, Kritchevsky S.. Blood. 2015;126(23):2102.
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Horton TM, Perentesis JP, Gamis AS, Alonzo TA, Gerbing RB, Ballard J, Adlard K, Howard DS, Smith FO, Jenkins G, Kelder A, Schuurhuis GJ, Moscow JA.. Pediatr Blood Cancer. 2014;61(10):1754-1760.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Professor, Hematology & Oncology
Acute and Chronic Leukemia, Acute Leukemias, Myelodysplastic Syndromes, Blood and Marrow Transplant, Hematologic Malignancies, Multiple Myeloma, Hematopoietic Stem Cell Transplantation, Bone Marrow and Stem Cell Transplantation, Leukemia
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
I really like Dr. Howard and look forward to being her patient!
Dr. Howard and her entire team have been great. They are very knowledgeable, compassionate, understanding and helpful. They always take the time to listen to my concerns and together we gone up with a treatment plan that works for me. This has been a long difficult journey and Dr. Howard, Mary, Brooke and Allison made it tolerable.
Dr. Howard was WONDERFUL!! She took the time to make sure I understood everything and even took the time to make sure my mom's questions were answered. She never rushed us even though my time with her was affected by the check in process.
Dr. Howard is wonderful very caring just the Best!
*Dr. Howard is the best. I'm sure I wouldn't be alive today w/out her. She is caring, _____ & all around AMAZING!
the cancer team saved my life.
*Dr. Howard had been really great along with everybody else.
*Dr. Howard has a sweet caring bedside manner second to none.
Diana Howard is the total physician. While treating your medical condition , she simultaneously makes you realize that she truly cares about the concerns, emotions, and questions of the PERSON behind the Patient Number. This wonderful trait, paired with her vast knowledge in this specialty area, is what makes her successful.
*Dr. Howard is amazing. I wouldn't of been able to get through this without her. She is the best!
Dr Howard, Mary, Brooke, and Philly are all awesome! they are very compassionate. they listen to my concerns make appropriate adjustments. they spend the time to get all the facts. I have always left feeling like they took good care of me and spent the necessary time to ensure that I understood what to do next. Brandy always ensures my medications are adjusted properly. Dr Howard, NP's and pharmacy work closely together ensuring I continue to improve.
Dr Howard is the absolute best doctor I have ever dealt with. The entire oncology team has more than well exceeded my expectations. She is very professional and knowledgable, yet so very personable. Your hospital has a rare gem in her. Excellent physician!
*Dr. Howard is the best!
Best MD I've ever had. Highly respected by staff.